Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways

Dong Woo Lim, Shambhunath Bose, Jing Hua Wang, Han Seok Choi, Young Mi Kim, Young Won Chin, Song Hee Jeon, Jai Eun Kim, Hojun Kim

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Samjunghwan (SJH) is an herbal formula used in traditional Korean medicine. This prescription has long been used in treatment of aging and lifestyle diseases. The current study showed the effect and mechanisms of anti-hepatic steatosis action of modified SJH (mSJH) in vitro and in vivo. Treatment with mSJH resulted in significantly decreased intracellular lipid accumulation in steatosis-induced cells. Furthermore, mSJH triggered the phosphorylation of AMP-activated protein kinase and acetyl-CoA carboxylase as well as increased the expression of leptin at both protein and gene levels. In addition, C57BL6 mice fed high-fat diet (HFD) showed significant improvements in body, liver weights and fat weights; and serum, hepatic and fecal lipid parameters in response to the treatment with mSJH. Furthermore, mSJH showed favorable effects on the hepatic expression of several genes related to lipid metabolism. Betaine, one of constituents of mSJH exerted fundamental beneficial impact on FFAs-induced cells. However, the beneficial effects of mSJH were diminished upon blocking of leptin signaling by dexamethasone, suggesting the leptin signaling as a key component in mSJH-mediated modulation of lipid homeostasis. Our results suggest that mSJH exerts an anti-hepatic steatosis effect via activation of leptin and associated signaling cascades related to lipid metabolism.

Original languageEnglish
Article number45425
JournalScientific Reports
Volume7
DOIs
StatePublished - 30 Mar 2017

Fingerprint

Dive into the research topics of 'Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways'. Together they form a unique fingerprint.

Cite this